HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elucidating the mode of action of a typical Ras state 1(T) inhibitor.

Abstract
The small GTPase Ras is an essential component of signal transduction pathways within the cell, controlling proliferation, differentiation, and apoptosis. Only in the GTP-bound form does Ras interact strongly with effector molecules such as Raf-kinase, thus acting as a molecular switch. In the GTP-bound form, Ras exists in a dynamic equilibrium between at least two distinct conformational states, 1(T) and 2(T), offering different functional properties of the protein. Zn2+-cyclen is a typical state 1(T) inhibitor; i.e., it interacts selectively with Ras in conformational state 1(T), a weak effector binding state. Here we report that active K-Ras4B, which is prominently found to be mutated in human tumors, exhibits a dynamic equilibrium like H-Ras, which can be modulated by Zn2+-cyclen. The titration experiments of Ras with Zn2+-cyclen indicate a cooperatively coupled binding of the ligands to the two interaction sites on Ras that could be identified for H-Ras previously. Our data further indicate that as in state 2(T) where induced fit produces the substate 2(T)* after effector binding, a corresponding substate 1(T)* can be detected at the state 1(T) mutant Ras(T35A). The interaction of Zn2+-cyclen with Ras not only shifts the equilibrium toward the weak effector binding state 1(T) but also perturbs the formation of substate 1(T)*, thus enhancing the inhibitory effect. Although Zn2+-cyclen shows an affinity for Ras in only the millimolar range, its potency of inhibition corresponds to a competitive state 2 inhibitor with micromolar binding affinity. Thus, the results demonstrate the mode of action and potency of this class of allosteric Ras inhibitors.
AuthorsIna C Rosnizeck, Daniel Filchtinski, Rui Pedro Lopes, Bärbel Kieninger, Christian Herrmann, Hans Robert Kalbitzer, Michael Spoerner
JournalBiochemistry (Biochemistry) Vol. 53 Issue 24 Pg. 3867-78 (Jun 24 2014) ISSN: 1520-4995 [Electronic] United States
PMID24866928 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Coordination Complexes
  • Cyclams
  • Heterocyclic Compounds
  • Heterocyclic Compounds, 1-Ring
  • Ligands
  • Guanosine Triphosphate
  • cyclen
  • raf Kinases
  • ras Proteins
Topics
  • Coordination Complexes (pharmacology)
  • Cyclams
  • Guanosine Triphosphate (metabolism)
  • Heterocyclic Compounds (pharmacology)
  • Heterocyclic Compounds, 1-Ring (pharmacology)
  • Humans
  • Ligands
  • Models, Molecular
  • Nuclear Magnetic Resonance, Biomolecular
  • Protein Binding
  • Protein Conformation
  • raf Kinases (metabolism)
  • ras Proteins (antagonists & inhibitors, chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: